Skip to main content

Table 1 Characteristics of the patients included into the medication risk analysis (n = 136)

From: Medication risks in older patients (70 +) with cancer and their association with therapy-related toxicity

Age [years]

 Mean (SD)

76.9 (4.53)

 

 Range

70–88

 

Charlson Comorbidity Indexa

 Mean (SD)

1.05 (1.237)

 

 Range

0–7

 

Creatinine Clearance (Cockcroft-Gault) [mL/min]

 Mean (SD)

67.2 (22.89)

 

 Range

10–131

 
 

n

%

Sex

 Female

68

50.0

 Male

68

50.0

ECOG performance status

 Fully active (0)

45

33.1

 Capable of all self-care (1–2)

74

54.4

 Limited or no self-care (3–4)

17

12.5

Tumor entityb

 Respiratory

34

25.0

 Hematological

57

41.9

 Gynecological

5

3.7

 Genitourinary

3

2.2

 Unknown primary

4

2.9

 Musculoskeletal

1

0.7

 Digestive/gastrointestinal

16

11.8

 Breast

13

9.6

 Others

3

2.1

Relapse

 No

118

86.8

 Yes

18

13.2

Cancer stage

 I

7

5.1

 II

11

8.1

 III

31

22.8

 IV

68

50.0

 Missing

19

14.0

Treatment type

 Chemotherapy

81

59.6

 Targeted or immunotherapy

9

6.6

 Combined chemotherapy and targeted or immunotherapy

46

33.8

  1. ECOG Eastern Cooperative Oncology Group
  2. a Considering conditions in addition to primary cancer diagnosis
  3. b By body location according to the National Cancer Institute (NCI)